Inventor
RAKESTRAW Ginger
US13 patents
⚠️ This page may combine multiple inventors who share the name “RAKESTRAW Ginger”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
9 patentsUS11926673B2Mar 12, 2024
Antagonistic CD40 monoclonal antibodies and uses thereof
BRISTOL MYERS SQUIBB CO4 citations84
US11254750B2Feb 22, 2022
Antagonistic CD40 monoclonal antibodies and uses in treating immune responses
BRISTOL MYERS SQUIBB CO6 citations84
US12419953B2Sep 23, 2025
Methods of treatment or prevention of immune responses and inflammatory diseases with antagonistic CD40 monoclonal antibodies
BRISTOL MYERS SQUIBB CO1 citations73
US11795231B2Oct 24, 2023
Antagonistic CD40 monoclonal antibodies and uses thereof
BRISTOL MYERS SQUIBB CO2 citations71
US11773178B2Oct 3, 2023
Antagonistic CD40 monoclonal antibodies and uses thereof
BRISTOL MYERS SQUIBB CO2 citations71
US11261258B2Mar 1, 2022
Antagonistic CD40 monoclonal antibodies and uses thereof
BRISTOL MYERS SQUIBB CO2 citations71
US10556948B2Feb 11, 2020
IP-10 antibodies and their uses
BRISTOL MYERS SQUIBB CO2 citations69
US12409223B2Sep 9, 2025
Antagonistic CD40 monoclonal antibodies and uses thereof
BRISTOL MYERS SQUIBB CO0 citations61
US11708405B2Jul 25, 2023
IP-10 antibodies and their uses
BRISTOL MYERS SQUIBB CO1 citations58
FIVE PRIME THERAPEUTICS INC
4 patentsUS12195535B2Jan 14, 2025
Antibodies binding to VISTA at acidic pH
FIVE PRIME THERAPEUTICS INC0 citations60
US11603406B2Mar 14, 2023
Antibodies binding to VISTA at acidic pH
FIVE PRIME THERAPEUTICS INC0 citations60
US12173069B2Dec 24, 2024
Antibodies binding to vista at acidic pH
FIVE PRIME THERAPEUTICS INC1 citations58
US12091462B2Sep 17, 2024
Antibodies binding to vista at acidic pH
FIVE PRIME THERAPEUTICS INC0 citations58